RCAN2 and Hepatic steatosis: The main innovation of the current study is that we first demonstrated that RCAN2 was highly expressed in the liver of mice with fatty liver by qRT-PCR and Western blot, and subsequently confirmed that serum RACN2 levels were also significantly elevated in NAFLD patients.